Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Photochem Photobiol B ; 40(2): 163-7, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9345784

ABSTRACT

Three Si(IV)-tetradibenzobarreleno-octabutoxyphthalocyanines (TDiBOPcs) bearing different axial ligands on the metal ion were studied for their tumour-localizing and-photosensitizing properties after i.v. injection via a Cremophor emulsion (0.35 mumol kg-1 b.w.) to Balb/c mice bearing an intramuscularly implanted MS-2 fibrosarcoma. In all cases, the maximum tumour accumulation of the photosensitizer (0.8-1.9 nmol g-1 of tissue) was found at 24 h after injection. The efficiency and selectivity of tumour targeting appeared to be dependent on the nature of the axial ligands; optimal values of these parameters were obtained in the case of the bis(trihexyl-siloxy)-substituted Si(IV)-TDiBOPc, which gave a 7-9 tumour/muscle ratio of phthalocyanine concentration at 24-48 h after injection. The extent of tumour response to PDT treatment was correlated with the concentration of the photosensitizer in the tumour tissue: upon 740 nm irradiation (180 mW cm-2, 200 J cm-2) at 48 h after injection of 0.35 mumol kg-1 of Si(IV)-TDiBOPc-C6H13, the tumour growth exhibited a delay of about 7 days.


Subject(s)
Fibrosarcoma/drug therapy , Indoles/therapeutic use , Organometallic Compounds/therapeutic use , Photosensitizing Agents/therapeutic use , Animals , Female , Fibrosarcoma/metabolism , Fibrosarcoma/therapy , Indoles/pharmacokinetics , Mice , Mice, Inbred BALB C , Molecular Structure , Organometallic Compounds/pharmacokinetics , Photosensitizing Agents/pharmacokinetics , Phototherapy
SELECTION OF CITATIONS
SEARCH DETAIL
...